The Ras switch in structural and historical perspective
Author:
Gasper Raphael1, Wittinghofer Fred1
Affiliation:
1. Max-Planck-Institut für molekulare Physiologie , Otto-Hahn-Str. 11 , D-44227 Dortmund , Germany
Abstract
Abstract
Since its discovery as an oncogene more than 40 years ago, Ras has been and still is in the focus of many academic and pharmaceutical labs around the world. A huge amount of work has accumulated on its biology. However, many questions about the role of the different Ras isoforms in health and disease still exist and a full understanding will require more intensive work in the future. Here we try to survey some of the structural findings in a historical perspective and how it has influenced our understanding of structure-function and mechanistic relationships of Ras and its interactions. The structures show that Ras is a stable molecular machine that uses the dynamics of its switch regions for the interaction with all regulators and effectors. This conformational flexibility has been used to create small molecule drug candidates against this important oncoprotein.
Publisher
Walter de Gruyter GmbH
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference143 articles.
1. Ahearn, I.M., Haigis, K., Bar-Sagi, D., and Philips, M.R. (2011). Regulating the regulator: posttranslational modification of RAS. Nat. Rev. Mol. Cell. Biol. 13, 39–51. 2. Ahmadian, M.R., Stege, P., Scheffzek, K., and Wittinghofer, A. (1997). Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras. Nat. Struct. Biol. 4, 686–689. 3. Aoki, Y., Niihori, T., Kawame, H., Kurosawa, K., and Ohashi, H. (2005). Germline mutations in HRAS protooncogene cause Costello syndrome. Nat. Genet. 37, 1038–1040. 4. Bandaru, P., Shah, N.H., Neel, H., Bhattacharyya, M., Barton, J.P., Kondo, Y., Cofsky, J.C., Gee, C.L., Chakraborty, A.K., Kortemme, T., et al. (2017). Deconstruction of the Ras switching cycle through saturation mutagenesis. eLife 6, e27810. 5. Bery, N., Cruz-Migoni, A., Bataille, C.J.R., Quevedo, C.E., Tulmin, H., Miller, A., Russell, A., Phillips, S.E., Carr, S.B., and Rabbitts, T.H. (2018). BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions. eLIFE 7, e37122.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|